Navigation Links
Dr. Tamer Seckin Comments on the Effects of Endometriosis on Miscarriages and Infertility
Date:10/25/2013

New York, New York (PRWEB) October 25, 2013

Last Tuesday, October 15, marked the anniversary of National Pregnancy and Infant Loss Remembrance Day. Women who find themselves having a hard time getting pregnant and having a child without miscarriage may have endometriosis to blame. In hopes of decreasing the number of miscarriages and educating women of the disorder, Dr. Seckin, co-founder of the Endometriosis Foundation of America, offers insight on endometriosis and how the disorder affects the fertility of women.

Endometriosis, a chronic gynecologic disorder, has an immunological component that can lead to miscarriages. The disorder is one of the leading causes of infertility in women, where medical studies show that 30 – 50% of women with endometriosis are infertile, and 21% – 44% of infertile women have endometriosis. Luckily, with proactive treatment, women can increase the probability of pregnancy.

This spring, leading gynecologic doctors and experts met at the Fourth Annual Scientific and Surgical Symposium sponsored by the Endometriosis Foundation of America in New York City to discuss infertility and early pregnancy loss in endometriosis patients. While doctors commonly agree that endometriosis affects the uterine lining and interferes with embryo implantation, many doctors are beginning to realize endometriosis can affect the egg quality itself.

“Many women want to have the American dream: two kids, a dog, and a white picket fence,” said Dr. Seckin. “Endometriosis does not have to be the end of that dream. It is cruel that the disease has led to the devastating experience of pregnancy loss. Early diagnosis and intervention are the best treatments.”

Egg freezing is an option for young women who are worried and proactive about their future family building. For women suffering with endometriosis, especially those with recurrent pregnancy loss, it is recommended to use in-vitro fertilization and pre-implantation genetic diagnosis to help achieve a healthy pregnancy.

Endometriosis can also leave a destructive path in a patient’s pelvis. Dr. Seckin has seen a great number of his patients go on to have healthy pregnancies after completing an Advanced Laparoscopic Excision Surgery on their pelvis to eliminate the source of inflammation. Without the surgery, scar tissue and adhesions can form on the Fallopian tubes, making it extremely dangerous for the woman because she must terminate the pregnancy before the tube ruptures.

About Dr. Seckin:

Dr. Tamer Seckin has focused on the surgical treatment of endometriosis for decades and today is a well-regarded expert in the field. His New York City based practice, Dr. Seckin Endometriosis Surgery, is known for its warm, dedicated and continuous patient care, exceptional skill and thoroughness. He is also the co-founder of the Endometriosis Foundation of America. As a leading endometriosis specialist and laparoscopic surgeon, Dr. Seckin understands the frustration that affected individuals may feel. Dr. Seckin's treatment approach is the gold standard--Advanced Laparoscopic Excision Surgery (deep removal of all the disease). He performs almost scar-free surgery, which means less pain and cosmetically acceptable results.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11253644.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
2. Aptamers Market to Reach $2.1 Billion by 2018 at A CAGR of 49.24% - New Report by MarketsandMarkets
3. Aptamers Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research
4. AADR comments on review that validates association between oral health and heart health
5. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
6. Kettlebell Training Expert Lorna Kleidman Comments on an Article about Risks of Ibuprofen Use for Athletes
7. MyBloodWorks Creator Glen Ogle Comments on New Study Linking Hypertension During Pregnancy to Later Heart Trouble
8. Bioforce AG Announces Doctors Comments Showing Efficacy of Echinaforce for Immune Support Now On You Tube
9. Fitness Expert Lorna Kleidman Comments on Article Concerning Weight Loss as a New Year’s Resolution
10. Quorn Foods Inc. Comments on an Article Regarding a Year in Review for Philadelphia’s Meatless Meals and the Restaurants That Serve Them
11. Kettlebell Exercises Expert Lorna Kleidman Comments on New Fitness Technology Gadgets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, ... of Cisco Select certification and SMB specialization. Altura is now qualified to ... In earning the Select Certification, Altura fulfilled the training and exam requirements for ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... ... 21, 2017 , ... Contrary to popular perception, a new ... at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a ... the United States. The study, Trends in Fighting and Violence Among Adolescents ...
(Date:4/21/2017)... ... ... Brady (NYSE:BRC), a global leader in industrial and safety printing ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally recognized ... for use on chemical drums shipped by sea. , “Achieving BS5609 certification ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
Breaking Medicine Technology: